Etiology, Risk Factors, and Biomarkers in Systemic Sclerosis ILD - Article
Etiology, Risk Factors, and Biomarkers in Systemic Sclerosis ILD - Article
Review guidance for the identification and medical management of systemic sclerosis-associated ILD in this concise clinical review from the American Thoracic Society.
What you’ll learn:
- The pathogenesis of SSc-ILD
- The genetics and epigenetics associated with the disease
- The cellular pathogenesis of fibrotic lung injury in SSc
- Risk factors for the development and progression of SSc-ILD
- Blood serum and BAL fluid markers used in SSc-ILD diagnosis and prognostication
- Characteristics of IPF compared to SSc-ILD, and the importance of differentiation between the two diseases
Related Resources
Chronic Fibrosing ILD with Progressive Phenotype - HCP Resource
Diagnosis of HP in Adults - Clinical Practice Guideline
Guidelines from the American Thoracic Society offering a systematic approach to diagnosing hypersensitivity pneumonitis (HP).
View Resource
Chronic Fibrosing ILD with Progressive Phenotype - HCP Resource
Autoimmune Disease-Associated Interstitial Lung Disease - Slide Deck
Review autoimmune connective tissue disorders (CTDs) associated with ILD.
View Resource
Chronic Fibrosing ILD with Progressive Phenotype - HCP Resource
Hypersensitivity Pneumonitis - Slide Deck
Discover the characteristics, epidemiology, and pathogenesis of HP.
View Resource
